Liposomes vs. Niosomes

What's the Difference?

Liposomes and niosomes are both types of vesicular drug delivery systems that have gained significant attention in the field of pharmaceutical sciences. Liposomes are spherical vesicles composed of lipid bilayers, while niosomes are similar structures formed by nonionic surfactants. Both liposomes and niosomes have the ability to encapsulate hydrophilic and hydrophobic drugs, protecting them from degradation and improving their bioavailability. However, liposomes have better stability and higher drug entrapment efficiency compared to niosomes. On the other hand, niosomes offer advantages such as lower cost, ease of preparation, and enhanced drug release properties. The choice between liposomes and niosomes depends on the specific requirements of the drug and the desired drug delivery characteristics.


CompositionPhospholipidsNonionic surfactants
StructureSpherical vesiclesSpherical vesicles
SizeVariable, typically 50-1000 nmVariable, typically 100-1000 nm
PreparationHydration of lipidsHydration of surfactants
StabilityRelatively unstableRelatively stable
Drug encapsulationHigh encapsulation efficiencyVariable encapsulation efficiency
BiocompatibilityGenerally biocompatibleGenerally biocompatible
Release rateControlled release possibleControlled release possible
ApplicationsDrug delivery, gene therapyDrug delivery, gene therapy

Further Detail


Liposomes and niosomes are both types of vesicular drug delivery systems that have gained significant attention in the field of pharmaceutical sciences. These systems offer unique advantages in terms of drug encapsulation, stability, and targeted delivery. In this article, we will compare the attributes of liposomes and niosomes, shedding light on their composition, preparation methods, stability, and applications.


Liposomes are composed of phospholipids, which are amphiphilic molecules consisting of a hydrophilic head and hydrophobic tail. These phospholipids self-assemble in an aqueous environment to form bilayer structures, with the hydrophilic heads facing the aqueous medium and the hydrophobic tails forming the interior. On the other hand, niosomes are composed of non-ionic surfactants, such as Span and Tween, which also self-assemble to form bilayer structures. The main difference lies in the composition, with liposomes being composed of phospholipids and niosomes being composed of non-ionic surfactants.

Preparation Methods

Liposomes can be prepared using various methods, including the thin-film hydration method, reverse-phase evaporation method, and sonication method. In the thin-film hydration method, a lipid film is formed by evaporating a solution of lipids, followed by hydration with an aqueous phase. The reverse-phase evaporation method involves the formation of a water-in-oil emulsion, which is then evaporated to obtain liposomes. Sonication, on the other hand, involves the application of high-frequency sound waves to disperse the lipid film and form liposomes. Niosomes, on the other hand, can be prepared using similar methods, including the thin-film hydration method and sonication method. The main difference lies in the composition of the lipid film, with niosomes using non-ionic surfactants instead of phospholipids.


Both liposomes and niosomes exhibit different stability profiles. Liposomes, due to their phospholipid composition, tend to be more stable in biological environments. The presence of cholesterol in liposomes further enhances their stability by reducing membrane fluidity. However, liposomes are susceptible to aggregation and leakage of encapsulated drugs over time. On the other hand, niosomes, being composed of non-ionic surfactants, may exhibit lower stability compared to liposomes. However, the addition of cholesterol or other stabilizing agents can improve the stability of niosomes. It is important to note that the stability of both vesicular systems can be influenced by factors such as temperature, pH, and the presence of ions.


Liposomes and niosomes have found numerous applications in the field of drug delivery. Liposomes have been extensively studied for their ability to encapsulate both hydrophilic and hydrophobic drugs, making them versatile carriers. They have been used for the delivery of anticancer drugs, antibiotics, and vaccines. Liposomes can also be modified to target specific cells or tissues, enhancing their therapeutic efficacy. Niosomes, on the other hand, have shown promise in the delivery of poorly soluble drugs. The non-ionic surfactants used in niosomes can solubilize hydrophobic drugs, improving their bioavailability. Niosomes have also been explored for transdermal drug delivery, as they can penetrate the skin more effectively compared to liposomes.


In conclusion, liposomes and niosomes are vesicular drug delivery systems with distinct attributes. Liposomes, composed of phospholipids, offer stability and versatility in drug encapsulation. Niosomes, composed of non-ionic surfactants, provide improved solubilization of hydrophobic drugs and enhanced transdermal delivery. Both systems have their advantages and limitations, and their selection depends on the specific requirements of the drug and the desired route of administration. Further research and development in these areas will continue to expand the applications of liposomes and niosomes in the field of pharmaceutical sciences.

Comparisons may contain inaccurate information about people, places, or facts. Please report any issues.